MACARTHYS LABORATORIES LIMITED
Get an alert when MACARTHYS LABORATORIES LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-11-08 (in 6mo)
Last made up 2025-10-25
Watchouts
None on the register
Cash
£19M
+7.6% vs 2023
Net assets
£86M
+0.1% vs 2023
Employees
463
+5.7% vs 2023
Profit before tax
£26M
-22.9% vs 2023
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £152,192,000 | £145,217,000 | |
| Operating profit | £32,775,000 | £24,721,000 | |
| Profit before tax | £33,516,000 | £25,841,000 | |
| Net profit | £31,391,000 | £25,073,000 | |
| Cash | £17,345,000 | £18,668,000 | |
| Total assets less current liabilities | £89,288,000 | £88,821,000 | |
| Net assets | £86,370,000 | £86,443,000 | |
| Equity | £86,370,000 | £86,443,000 | |
| Average employees | 438 | 463 | |
| Wages | £18,638,000 | £19,206,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 21.5% | 17.0% | |
| Net margin | 20.6% | 17.3% | |
| Return on capital employed | 36.7% | 27.8% | |
| Gearing (liabilities / total assets) | 40.2% | 41.4% | |
| Current ratio | 2.10x | 2.06x | |
| Interest cover | 275.42x | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Grant Thornton UK LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors consider, after making appropriate enquiries, that the Company has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements.”
Significant events
- “As part of a strategic realignment within the UK group, the Company transferred responsibility for the sale of its opioid addiction branded product portfolio to fellow group company, Ethypharm UK Limited, in September 2024.”
- “A short-term reduction in Company turnover resulted from the recent restructuring of the UK product portfolio.”
- “Restructuring costs, including redundancy costs, consultancy and legal fees, were incurred due to changes in operational structure.”
- “A dividend of £25.0m was proposed, approved and distributed during the year ended 31 December 2024 (2023: no dividend).”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 62 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| RUYANT, Foucauld | Secretary | 2024-09-30 | — | — |
| DE ULTRA DE SOUSA BARCELOS, Bruno | Director | 2023-01-17 | Aug 1973 | Portuguese |
| LASSERRE, Xavier Pierre Christian | Director | 2023-06-26 | Apr 1972 | French |
| MEHRAI, Alexander | Director | 2025-01-31 | Jun 1975 | British |
| RUYANT, Foucauld | Director | 2024-09-30 | Oct 1975 | French |
Show 62 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DAVIES, John Richard Bridge | Secretary | 1997-03-14 | 1997-08-08 |
| EARNSHAW, Jeremy Waring | Secretary | 2000-12-11 | 2005-09-30 |
| EBRAHIMJEE, Mahmood | Secretary | — | 1997-03-14 |
| KNIGHT, Anthony | Secretary | 2007-07-13 | 2010-06-30 |
| LOFTHOUSE, Stephen David | Secretary | 2006-03-06 | 2006-11-03 |
| PINCHIN, Nicholas John | Secretary | 1997-08-08 | 2000-12-11 |
| RILEY, Rodney Hardwicke | Secretary | — | 1992-05-20 |
| WEST, David William | Secretary | 2006-11-03 | 2007-07-12 |
| EVERSECRETARY LIMITED | Corporate Secretary | 2005-09-30 | 2006-03-06 |
| AMBROSE, Linda Anne | Director | 1994-04-01 | 1994-04-04 |
| AMBROSE, Linda Anne | Director | 1993-04-01 | 1993-03-08 |
| AXTEN, Godfrey Clive | Director | 2001-02-12 | 2002-01-07 |
| BOVOLENTA, Andrea | Director | 2024-03-01 | 2024-06-05 |
| BRYANT, Derek | Director | 1994-08-01 | 2002-03-31 |
| BUCKELL, Stephen William | Director | — | 1997-05-30 |
| CLARK, Michael Leslie | Director | 2014-05-12 | 2017-02-28 |
| COMERFORD, Martin James | Director | 2000-04-01 | 2006-02-28 |
| CONCANNON, Paul Joseph | Director | 2019-03-11 | 2025-01-31 |
| DE SOUZA, Richard Anthony | Director | 2010-09-28 | 2014-01-06 |
| DELUARD, Bertrand | Director | 2019-03-11 | 2022-09-13 |
| EARNSHAW, Jeremy Waring | Director | 2000-12-11 | 2005-09-30 |
| ENGELEN, Thomas | Director | 2010-05-12 | 2011-11-15 |
| FELLOWS, Jonathan | Director | 1995-07-03 | 1997-01-21 |
| GORMAN, Richard | Director | 1991-09-03 | 1993-01-29 |
| GROVER, Jason | Director | 2011-06-10 | 2017-02-28 |
| HARRIS, Michael Christopher James | Director | 2014-07-07 | 2019-01-01 |
| HARTY, Linda Anne | Director | 2006-12-18 | 2009-12-01 |
| JOANNESSE, Roseline Georgette | Director | 2017-02-28 | 2019-03-11 |
| KARLSSON, Tommy Harry Vilhelm | Director | 2014-01-06 | 2017-02-28 |
| KAY, Andrew George | Director | 2003-01-02 | 2005-12-31 |
| KERSHAW, Graham Anthony | Director | 1997-01-21 | 1997-08-08 |
| KITTLE, Ian Francis | Director | 2000-04-01 | 2002-01-02 |
| LANNING, Michael George | Director | 1999-12-01 | 2002-03-28 |
| LLOYD, Allen John | Director | — | 1997-01-21 |
| LLOYD, Peter Edward | Director | — | 1995-06-13 |
| LOFTHOUSE, Stephen David | Director | 2006-03-06 | 2006-03-06 |
| MEISTER, Stefan Mario | Director | 1997-01-21 | 1997-08-08 |
| MONIN, Jean Bernard Claude | Director | 2022-11-01 | 2023-06-26 |
| OADES, Andrew Giovanni | Director | 2003-10-01 | 2010-07-13 |
| OAKLEY, Stephen Edward | Director | — | 1993-03-08 |
| OLIVER, Diana Saira | Director | 2000-10-01 | 2008-10-15 |
| PARKER, John Francis | Director | 2000-11-24 | 2004-09-03 |
| PARRY, Philip Edward | Director | 2010-08-06 | 2022-12-31 |
| PARSONS, Ian Dominic | Director | — | 1993-03-08 |
| PINCHIN, Nicholas John | Director | 1998-02-05 | 2001-02-16 |
| RUE, Peter John, Doctor | Director | 1998-04-06 | 1999-08-20 |
| SAUNDERS, Martin John | Director | 1997-09-03 | 2005-09-30 |
| SAUNDERS, Martin John | Director | 1993-04-01 | 1997-08-08 |
| SAUNDERS, Martin John | Director | 1993-04-01 | 1993-03-08 |
| SCHMIDT, Emmanuel | Director | 2019-03-11 | 2022-12-31 |
| SILLITTO, Martin | Director | 2007-07-13 | 2012-01-26 |
| SIMPKINS, David Edward | Director | — | 1993-03-08 |
| STEELE, Richard John | Director | — | 1994-04-15 |
| TAYLOR, Malcolm Archibald, Doctor | Director | 2002-03-11 | 2005-09-30 |
| THOM, Edward Wilson | Director | 1994-08-01 | 2008-11-02 |
| TITTERSHILL, Andrew David | Director | 2002-03-01 | 2007-03-16 |
| TURNER, Richard Gill | Director | — | 1997-01-21 |
| VIZARD, Ronald Charles, Harold | Director | 1997-01-21 | 1997-08-08 |
| WARD, Michael Ashley | Director | 1994-07-18 | 1997-01-21 |
| WARRILOW, Colin William | Director | — | 1993-03-08 |
| WATSON, Terence | Director | 1991-09-03 | 1992-06-08 |
| WEST, David William | Director | 1991-09-03 | 2007-07-12 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Orphea Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2017-12-21 | Active |
| Martindale Pharma (Holdings 1) Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2017-12-21 |
Filing timeline
Last 20 of 296 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-10-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-19 | AA | accounts | Accounts with accounts type full | |
| 2025-01-31 | AP01 | officers | Appoint person director company with name date | |
| 2025-01-31 | TM01 | officers | Termination director company with name termination date | |
| 2024-12-12 | AA | accounts | Accounts with accounts type full | |
| 2024-10-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-17 | AP03 | officers | Appoint person secretary company with name date | |
| 2024-10-17 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-17 | AP01 | officers | Appoint person director company with name date | |
| 2024-03-01 | AP01 | officers | Appoint person director company with name date | |
| 2023-10-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-24 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-10-03 | AA | accounts | Accounts with accounts type full | |
| 2023-07-10 | TM01 | officers | Termination director company with name termination date | |
| 2023-07-10 | AP01 | officers | Appoint person director company with name date | |
| 2023-05-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-01-27 | TM01 | officers | Termination director company with name termination date | |
| 2023-01-27 | AP01 | officers | Appoint person director company with name date | |
| 2023-01-27 | TM01 | officers | Termination director company with name termination date | |
| 2022-12-07 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-4.6%
£152,192,000 £145,217,000
-
Cash
+7.6%
£17,345,000 £18,668,000
-
Net assets
+0.1%
£86,370,000 £86,443,000
-
Employees
+5.7%
438 463
-
Operating profit
-24.6%
£32,775,000 £24,721,000
-
Profit before tax
-22.9%
£33,516,000 £25,841,000
-
Wages
+3%
£18,638,000 £19,206,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers